Rice Partnership’s Bristol-Myers Squibb BMY Stock Holding History

Rice Partnership’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,928	Closed	-$203K	–	140
2023 Q1	$203K	Hold	2,928	–	–	0.06%	88
2022 Q4	$211K	Hold	2,928	–	–	0.07%	82
2022 Q3	$208K	Buy	+2,928	New	+$212K	0.07%	86
2021 Q1	–	Sell	-3,228	Closed	-$200K	–	111
2020 Q4	$200K	Sell	3,228 -600	-16%	-$36.9K	0.07%	86
2020 Q3	$231K	Sell	3,828 -3,887	-50%	-$234K	0.1%	70
2020 Q2	$454K	Sell	7,715 -1,076	-12%	-$64.4K	0.23%	48
2020 Q1	$490K	Buy	8,791 +256	+3%	+$15.6K	0.33%	46
2019 Q4	$548K	Sell	8,535 -165	-2%	-$9.45K	0.3%	50
2019 Q3	$441K	Sell	8,700 -684	-7%	-$32.1K	0.28%	55
2019 Q2	$426K	Sell	9,384 -850	-8%	-$39.6K	0.29%	57
2019 Q1	$488K	Sell	10,234 -1,700	-14%	-$84.7K	0.35%	53
2018 Q4	$620K	Sell	11,934 -4,250	-26%	-$228K	0.56%	42
2018 Q3	$1M	Sell	16,184 -9,895	-38%	-$587K	0.63%	40
2018 Q2	$1.44M	Buy	26,079 +486	+2%	+$26.2K	0.95%	35
2018 Q1	$1.62M	Sell	25,593 -9,049	-26%	-$582K	1.08%	31
2017 Q4	$2.12M	Buy	+34,642	New	+$2.17M	1.49%	22

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Rice Partnership's BMY Position: Q2 2023 in Review

Rice Partnership sold out of Bristol-Myers Squibb (BMY) in Q2 2023, closing a stake of 2,928 shares — an estimated $203K sold.

Rice Partnership first reported a position in BMY in Q4 2017 and held it in 16 quarters. The position peaked at $2.12M in Q4 2017. 2,480 funds tracked by Wall St. Rank hold BMY as of Q2 2023.

Rice Partnership reported no remaining Bristol-Myers Squibb position as of Q2 2023 after selling out during the quarter.
Rice Partnership sold 2,928 Bristol-Myers Squibb shares in Q2 2023, an estimated $203K.
Rice Partnership first reported a position in Bristol-Myers Squibb in Q4 2017 and held it in 16 quarters.
Rice Partnership's Bristol-Myers Squibb position peaked at $2.12M in Q4 2017.
2,480 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.

Based on Rice Partnership's 13F filing for Q2 2023, filed 8 Aug 2023.